tiprankstipranks
Advertisement
Advertisement
NanoViricides emphasizes need for Ebolavirus antiviral drug
PremiumThe FlyNanoViricides emphasizes need for Ebolavirus antiviral drug
22d ago
NanoViricides prices $2M registered direct offering
Premium
The Fly
NanoViricides prices $2M registered direct offering
25d ago
NanoViricides reports Q1 EPS (9c) vs. (14c) last year
Premium
The Fly
NanoViricides reports Q1 EPS (9c) vs. (14c) last year
25d ago
NanoViricides files application for RPDD for NV-387 with U.S. OPDD
PremiumThe FlyNanoViricides files application for RPDD for NV-387 with U.S. OPDD
2M ago
NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox
Premium
The Fly
NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox
2M ago
NanoViricides completes manufacture of NV-387 oral gummies
Premium
The Fly
NanoViricides completes manufacture of NV-387 oral gummies
3M ago
NanoViricides files to sell 7.14 shares of common stock for holders
PremiumThe FlyNanoViricides files to sell 7.14 shares of common stock for holders
6M ago
NanoViricides signs Master Services Agreement with Only Orphans Cote
Premium
The Fly
NanoViricides signs Master Services Agreement with Only Orphans Cote
6M ago
NanoViricides Holds 2025 Annual Stockholders Meeting
Premium
Company Announcements
NanoViricides Holds 2025 Annual Stockholders Meeting
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100